Robert W. Schrepfer is VP at ANI PHARMACEUTICALS INC (ANIP). They have made 1 open-market trade across 1 company since 2019, most recently 2019-03-13.
CIK 0001579464
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ANIP | 47,842 | $3.5M |
Shares reported on the most recent Form 4, priced at the 2019-03-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANIP | SELL | 2019-03-12 | 2019-03-14 | $64.44 | $760K | +6.4% | +7.1% | +10.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.